Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 11, 2024
Immune
checkpoint
inhibitors
(ICIs)
treatment
have
shown
high
efficacy
for
about
15
cancer
types.
However,
this
therapy
is
only
effective
in
20-30%
of
patients.
Thus,
the
precise
biomarkers
ICI
response
are
an
urgent
need.
Journal of Immunoassay and Immunochemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 14
Published: March 18, 2025
IL2
is
one
of
the
key
cytokines
essential
for
regulating
immune
system
and
inflammation-related
carcinogenesis
process.
Few
studies
have
examined
relationship
between
lung
cancer
IL2-330
(rs2069762)
gene
polymorphism,
despite
several
demonstrating
that
it
linked
to
numerous
types.
Our
study
aimed
investigate
association
polymorphism
risk
explore
role
in
survival
outcomes
(OS
PFS).
The
was
conducted
from
October
2023
November
2024,
including
50
randomly
selected
patients
diagnosed
with
subjects
matched
age
gender
were
used
as
controls
this
case-control
study.
assessed
using
real-time
PCR.
We
found
AC
genotype
associated
a
notably
lower
comparison
AA
(95%
CI:
0.06-0.61,
p
=
0.01).
Conversely,
CC
showed
no
significant
when
compared
reference
genotype.
comprehensive
distributions
among
AA,
AC,
genotypes
through
Log-Rank
(Mantel-Cox)
test
indicated
statistically
difference.
According
our
research,
significantly
higher
rate
cancer.
Further
future
are
needed
confirm
these
findings.
Thoracic Cancer,
Journal Year:
2025,
Volume and Issue:
16(7)
Published: April 1, 2025
ABSTRACT
Background
Esophageal
squamous
cell
carcinoma
(ESCC)
is
a
prevalent
and
deadly
cancer,
making
it
essential
to
understand
the
molecular
mechanisms
influencing
its
development
prognosis.
The
role
of
interferon‐gamma‐inducible
protein
30
(IFI30)
in
antigen
processing
well‐established,
but
impact
on
progression
ESCC
remains
unclear.
This
study
aimed
investigate
biological
function
potential
IFI30
progression.
Methods
Public
databases,
proteomics,
immunohistochemistry
(IHC)
were
employed
analyze
expression.
Cell
proliferation,
migration,
invasion
evaluated
using
MTS,
colony
formation,
wound
healing,
transwell
assays.
Nude
mouse
xenograft
models
established
assess
effects
knockdown
vivo.
Quantitative
proteomics
was
utilized
identify
differentially
expressed
proteins
(DEPs)
pathways
altered
by
knockdown.
apoptosis
senescence
flow
cytometry,
SA‐β‐gal
staining,
reactive
oxygen
species
(ROS)
analysis.
Results
highly
correlated
with
advanced
stage
poor
inhibited
vitro
suppressed
tumor
growth
DEPs
mainly
enriched
related
apoptosis,
mitophagy,
cellular
senescence,
lysosome.
Furthermore,
cells
upregulated
HRAS
expression,
increased
ROS
production,
activated
JNK
signaling
pathway,
elevated
expression
P16
P21,
thereby
promoting
senescence.
Conclusions
suggests
that
may
regulate
P21/P16
pathways,
exerting
pro‐tumorigenic
ESCC.
could
serve
as
novel
target
for
treatment.
Pharmacognosy Magazine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 28, 2025
Background
Lung
cancer
is
a
deadly
type
of
and
the
primary
cause
cancer-related
deaths
in
both
males
females
worldwide.
The
number
lung
cases
has
risen
worldwide
due
to
growing
population
smokers
an
increase
environmental
pollutants.
Purpose
current
study
was
dedicated
studying
anti-cancer
immunomodulatory
activities
nuciferine
against
B[a]P-induced
mice.
Methods
initiated
BALB/c
mice
by
challenging
them
with
B[a]P
for
4
weeks.
post-
pre-treatment
25
mg/kg
given
B[a]P-challenged
mice’s
body
weight,
tumor
incidences,
numbers
were
tabulated.
biochemical
markers,
immunoglobulins
(Igs),
phase-I
-II
detoxification
enzymes,
mitochondrial
enzyme
assessed
using
standard
techniques.
levels
inflammatory
cytokines
biomarkers
evaluated
assay
kits.
histopathological
analysis
conducted
tissues
experimental
Results
Both
successfully
increased
weight
reduced
incidence,
numbers.
treatment
effectively
regulated
parameters
Igs.
Furthermore,
modulated
biomarkers,
cytokine
levels.
findings
also
proved
efficacy
cancer.
Conclusion
present
suggest
that
exhibits
chemopreventive
properties
Therefore,
it
evident
possesses
can
potentially
enhance
chemotherapy
treatments.
Translational Cancer Research,
Journal Year:
2024,
Volume and Issue:
13(10), P. 5649 - 5663
Published: Oct. 1, 2024
The
occurrence
and
development
of
tumors
in
human
tissues
widely
depend
on
their
surrounding
environment,
known
as
the
tumor
microenvironment
(TME),
which
comprises
various
cells,
molecules,
blood
vessels.
Through
modifications,
organization,
integration,
these
elements
serve
potential
therapeutic
targets
anti-cancer
therapy,
supporting
promoting
proliferation,
invasion,
metabolism
cells.
Cytokines
within
TME
are
responsible
for
immune
cell
activation,
differentiation,
thereby
influencing
tumor's
behavior.
This
article
reviews
use
cytokines
immunotherapy
combs
network
signals
that
mediate
malignancies.
Biological Trace Element Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 3, 2024
Abstract
The
aim
of
this
study
was
to
investigate
the
dose-dependent
adverse
effects
long-term
dietary
lithium
administration
on
specific
aspects
defense
system
in
rats.
Additionally,
aimed
explore
inflammatory
activities
beyond
its
recognized
anti-inflammatory
properties.
Forty
Wistar
Albino
rats
were
involved,
which
randomly
allocated
into
control
and
four
treatment
groups.
group
received
standard
rat
feed,
experimental
groups’
diet
added
1
g/kg,
1.4
1.8
2.2
g/kg
bicarbonate,
respectively.
CD4+,
CD8+,
CD161
+
cells
assessed
by
flow
cytometry.
TNF-α,
IFN-γ,
IL-1β,
IL-2
IL-4,
IL-6,
IL-10
levels
measured.
proportion
CD4
CD4+/CD8
ratio
(
P
=
0.005
0.038,
respectively)
reduced
with
highest
dose
compared
group.
data
regarding
pro-inflammatory
cytokines
showed
a
increase
serum
TNF-α
IFN-γ
0.023
0.001,
respectively).
On
other
hand,
IL-1β
decreased
manner
0.
001
001,
As
for
cytokines,
decrease
determined
IL-4
level
0.002),
while
no
significant
changes
noted
IL-6
0.507
0.732,
In
conclusion,
adversely
impacted
cellular
system.
Furthermore,
apart
from
properties,
exhibited
cytokine-mediated
activities.
Therefore,
lithium’s
potential
immune
should
be
considered
immunodeficient
patients
those
an
status
treated
high
doses
lithium.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(6), P. 1113 - 1113
Published: March 10, 2024
The
intricate
interplay
between
inflammatory
processes
and
the
tumor
microenvironment
(TME)
in
lung
cancer
has
garnered
increasing
attention
due
to
its
implications
for
both
oncogenesis
therapeutic
strategies.
In
this
review,
we
explore
recent
advances
understanding
paracrine
regulation
immune
system
pathways
within
TME
of
cancer.
We
delve
into
molecular
mechanisms
underpinning
oncogenesis,
highlighting
role
cell
populations,
cancer-associated
fibroblasts,
endothelial
cells,
as
well
their
interactions
through
regulated
a
pattern.
Additionally,
discuss
emerging
immunotherapeutic
strategies
with
specific
focus
on
potential
leveraging
these
enhance
treatment
efficacy
Turkish Journal of Biochemistry,
Journal Year:
2024,
Volume and Issue:
49(3), P. 430 - 438
Published: May 2, 2024
Abstract
Objectives
Lung
cancer
remains
a
predominant
type
with
high
incidence
and
low
survival
rates.
Key
challenges
in
its
treatment
include
impaired
cellular
mechanisms,
notably
resistance
to
apoptosis
altered
immune
responses.
A
critical
aspect
this
context
is
the
heightened
TLR4-mediated
signaling,
known
promote
cell
survival,
metastasis,
death,
particularly
impacting
microenvironment
regulation.
This
study
focuses
on
evaluating
impact
of
TLR4
signaling
activation
potential
therapeutic
strategies.
Methods
Our
research
utilizes
cannabidiol
(CBD),
compound
already
employed
mitigating
chemotherapy
side
effects
lung
adenocarcinoma,
recognized
for
antitumor
properties
including
antiproliferative,
antimetastatic,
apoptosis-inducing
effects.
However,
effectiveness
CBD
cells
elevated
uncertain.
Results
findings
reveal
that
combination
agonist
affects
viability,
proliferation,
cycle
progression,
apoptosis,
gene
expression
related
response
extracellular
matrix
In
adenocarcinoma
activated
TLR4,
shows
an
increased
IC
50
value,
reflecting
reduced
antiproliferative
capacity.
Furthermore,
efficacy
arresting
inducing
also
compromised.
The
influence
regulation
TLR4-activated
cells.
Conclusions
These
results
indicate
significantly
diminishes
CBD.
highlights
importance
considering
future
agents
like
treatment.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(6), P. 621 - 621
Published: May 21, 2024
NRF2
activation
protects
epithelial
cells
from
malignancy,
but
cancer
can
upregulate
the
pathway
to
promote
survival.
activators
including
CDDO-Methyl
ester
(CDDO-Me)
inhibit
in
preclinical
models,
suggesting
other
cell
types
may
anti-tumor
activity.
However,
immunomodulatory
effects
of
remain
poorly
understood
context
cancer.
To
test
CDDO-Me
a
murine
model
established
lung
cancer,
tumor-bearing
wildtype
(WT)
and
Nrf2
knockout
(KO)
mice
were
treated
with
50–100
mg
CDDO-Me/kg
diet,
alone
or
combined
carboplatin/paclitaxel
(C/P)
for
8–12
weeks.
decreased
tumor
burden
an
Nrf2-dependent
manner.
The
combination
plus
C/P
was
significantly
(p
<
0.05)
more
effective
than
either
drug
alone,
reducing
by
84%
WT
mice.
reduced
histopathological
grade
tumors,
higher
proportion
low-grade
tumors
lower
high-grade
tumors.
These
changes
augmented
C/P.
also
protected
C/P-induced
toxicity
improved
macrophage
T
phenotypes
mice,
expression
CD206
PD-L1
on
macrophages,
decreasing
immunosuppressive
FoxP3+
CD4+
cells,
increasing
CD8+